NCT05905315View on ClinicalTrials.gov

Primary Chemoradiation VS. Neoadjuvant Chemotherapy Followed By Surgery As Treatment Strategy For LAVC

PHASE2RecruitingINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

September 1, 2029

Study Completion Date

September 1, 2029

Conditions
Locally Advanced Vulvar CarcinomaSquamous Cell Carcinoma of the Vulva
Interventions
DRUG

Paclitaxel and Carboplatin

Paclitaxel 175 mg/m2, followed by carboplatin 5 area under the curve (AUC). This will be administered in a 3-weekly scheme.

COMBINATION_PRODUCT

Chemoradiation

According to standard treatment.

Trial Locations (2)

Unknown

RECRUITING

NKI-AVL, Amsterdam

RECRUITING

LUMC, Leiden

All Listed Sponsors
lead

The Netherlands Cancer Institute

OTHER